
Market Analysis
Iambic Raises $150M in IPO for AI Drug Discovery
TL;DR: Iambic Therapeutics announced on October 14, 2026 that it priced 9,375,000 shares at $16.00, for gross proceeds of $150.0 million before underwriting discounts and expenses. Trading on the Nas…
Jeff Barnes, MBA··5 min read

Market Analysis
Iambic Raises $150M in an AI Drug Discovery IPO
TL;DR: Iambic Therapeutics, a San Diego AI drug discovery company, raised $150 million in its IPO, per BioPharma Dive , selling about 9.4 million shares at $16 each. It trades on Nasdaq as IAM from O…
Jeff Barnes, MBA··6 min read